'Jumping genes' help stabilize DNA folding patterns

The DNA molecule inside the nucleus of any human cell is more than six feet long. To fit into such a small space, it must fold into precise loops that also govern how genes are turned on or off. New research indicates that 'jumping genes' play a surprising role in stabilizing the 3D folding patterns of the DNA molecule inside the cell's nucleus.

For more information about latest research in the field of Biosimilars and Biomarkers, Join us at "International Conference on Biosimilars-Biologics and Biomarkers" which is going to be held in Barcelona,Spain during November 16-17, 2020.

Biosimilars-2020

ABOUT CONFERENCE

Conference Series LLC Ltd, Scientific Event Organizer and the World Class Open Access Publisher invites all the participants from all over the world to attend “International Conference on Biosimilars Biologics & Pharmaceuticals” (Biosimilars-2020) slated on November 16-17, 2020, Barcelona, Spain which covers on all aspects of the pharmaceutical sciences, manufacturing, quality with strong emphasis on originality and scientific quality. This Biosimilars-2020 setting a platform for all the budding Scientists and Researchers to present their real-time work and share their views and aspects related to the theme of the Conference. The Organizing committee is gearing up for an exciting and informative Conference program including plenary Lectures, Symposia, Workshops on a variety of topics, Poster presentations and various programs for participants from all over the World.

Biosimilars-2020 conveys recent developments in Pharma drug marketing and production of Pharma drugs and contract manufacturing. A complete knowledge of a scientific discipline that described the effects of Biosimilars drug marketing and Biosimilars Pharma now explores the Scope of Biosimilars drug marketing in industry & provides detailed market, technology, and industry analyses to help readers quantify and qualify the market for prescription generic drugs. Important trends are identified and sales forecasts by product categories and major country markets these are based on industry sources and considered assessment of the regulatory environment, healthcare policies, demographics, and other factors that directly affect the generic drug market. The wider economic environment is also considered.

Conference Highlights

• Biosimilars
• Biologics
• Bio similars and Bio-Pharmaceuticals
• Biomarkers
• Emerging Biosimilars in Therapeutics
• Clinical development of Biosimilars
• Pharmacovigilance challenges in Biosimilars
• Globilization of Biosimilars
• Biosimilars and Biologics
• Biosimilars vs Generics
• Bio-pharmaceuticals
• Bio-equivalence Assessment
• Biosimilar Cost Analysis and Market Analysis
• Plant Produced Biosimilar Products
• Biosimilar Analytical Strategies
• Immunogenicity of Biosimilars
• Monoclonal Antibody Biosimilars
• Emerging Trends in Biosimilars
• Future of Biosimilars
• Regulatory Approach of Biosimilars
  
  

Special Issues
 - All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

 - Abstracts will be provided with Digital Object Identifier by Cross Ref.

  See more at: https://biomarkers.healthconferences.org/